76632-20-7 Usage
General Description
ISOXAZOLE, 3-(BROMOMETHYL)- is a chemical compound that belongs to the class of isoxazoles, which are heterocyclic compounds containing an oxygen and nitrogen atom in a five-membered ring. The presence of the bromomethyl group in the compound makes it a versatile building block for the synthesis of various organic compounds, especially in medicinal chemistry and pharmaceutical research. ISOXAZOLE, 3-(BROMOMETHYL)- has potential applications in the development of drugs, agrochemicals, and other biologically active compounds due to its ability to undergo various chemical reactions to produce derivatives with different properties and functions. As a result, ISOXAZOLE, 3-(BROMOMETHYL)- is an important chemical component with diverse applications in the field of chemical synthesis and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 76632-20-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,6,3 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 76632-20:
(7*7)+(6*6)+(5*6)+(4*3)+(3*2)+(2*2)+(1*0)=137
137 % 10 = 7
So 76632-20-7 is a valid CAS Registry Number.
76632-20-7Relevant articles and documents
AMINE COMPOUND FOR INHIBITING SSAO / VAP-1 AND USE THEREOF
-
Paragraph 0282; 0287; 0635-0637, (2020/12/13)
An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
BENZIMIDAZOLE DERIVATIVES AS SELECTIVE ACID PUMP INHIBITORS
-
Page/Page column 47, (2008/06/13)
Abstract This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: R1, R2, R3, R4, A and E are each as described herein or a pharmaceutically acceptable salt
